27 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... of Sickle Cell Crises ... Clinical Manifestations ... #Hematology #SickleCell ... Manifestations #Workup #Algorithm
Suggested algorithm for follow-up of monoclonal gammopathy of undetermined significance (MGUS)
Mayo Clinic Risk Stratification Model. CBC,
Suggested algorithm ... significance (MGUS) Mayo Clinic ... MGUS #Followup #algorithm ... #diagnosis #management ... #hematology #multiplemyeloma
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilic Syndrome • Clinically ... and Treatment Algorithm ... Syndrome #HES #Hematology ... eosinophils #diagnosis #management ... #algorithm
Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined
Suggested algorithm ... whom there are no clinical ... #MGUS #Biopsy #algorithm ... #diagnosis #management ... #hematology #multiplemyeloma
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... Thrombosis and Management ... Extension #VTE #DVT #Hematology ... #Management #Diagnosis ... #Differential #Causes
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Rare (SSA+ for cutaneous ... Discontinuation of causal ... 40, F:M 9:1 • Clinical ... comparison #table #rheumatology
Our approach to the diagnosis and initial management of patients with suspected HIT. Our approach is
diagnosis and initial management ... based primarily on clinical ... #Diagnosis #Management ... #Hematology #HIT ... Thrombocytopenia #Algorithm
Disseminated Intravascular Coagulation (DIC) Overview

Increased Clotting and Consumption of Clotting Factors

Findings:
 • Bleeding
 • Recent history
organ damage Clinical ... involvement (2%) Cutaneous ... Treat primary cause ... #treatment #management ... #hematology
If you haven't seen it, flecainide can cause significant yellowing of the skin and eyes.
flecainide can cause ... #flecainide #cutaneous ... #sideeffects #clinical ... #photo #nails # ... cardiology #dermatology
ANTI-MDA5 DERMATOMYOSITIS

Cutaneous manifestations:
• Periorbital heliotrope (blue-purple) rash with edema
• Erythematous rash on the face, or the
DERMATOMYOSITIS Cutaneous ... auricular papules Clinical ... Men • ~50% of cases ... Dermatomyositis #rheumatology ... #dermatology #diagnosis